|
Ulf J. Johansson has served as a director of the Company since December 1999. Dr. Johansson is a Swedish national with a distinguished career in communications technology. He was a founder and served as chairman of Europolitan Vodafone AB, a GSM mobile telephone operator in Sweden, from 1990 until March 2005. In April 2005 Dr. Johansson was elected to the board of directors of Telefon AB LM Ericsson. He currently also serves as chairman of the board of directors for AcandoFrontec AB, an IT and management consulting company and Eurostep Group AB, a software and consulting company specializing in product life cycle management. Dr. Johansson has served on the board of directors of Novo Nordisk A/S, a Danish pharmaceutical/life science company since 1998, but left that position in March 2005 to serve as chairman of Novo Nordisk Foundation and Novo A/S, the private Danish investment company and parent company of the Novo Group as well as the majority owner of Novo Nordisk A/S and Novozymes A/S. From 1998 to 2003 Dr. Johansson served as chairman of the University Board of Royal Institute of Technology in Stockholm. Earlier positions include: president and chief executive officer of Spectra-Physics, and executive vice president of Ericsson Radio Systems AB. Dr. Johansson received a Master of Science in Electrical Engineering, and a Doctor of Technology (Communication Theory) from the Royal Institute of Technology in Sweden. | 